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Abstract
Studies of T cell-mediated immunity in the human female genital tract have been problematic due to difficulties associated
with the collection of mucosal samples. Consequently, most studies rely on biopsies from the lower female genital tract or
remnant tissue from hysterectomies. Availability of samples from healthy women is limited, as most studies are carried out
in women with underlying pathologies. Menstruation is the cyclical sloughing off of endometrial tissue, and thus it should
be a source of endometrial cells without the need for a biopsy. We isolated and phenotyped T cells from menstrual and
peripheral blood and from endometrial biopsy-derived tissue from healthy women to determine the types of T cells present
in this compartment. Our data demonstrated that T cells isolated from menstrual blood are a heterogeneous population of
cells with markers reminiscent of blood and mucosal cells as well as unique phenotypes not represented in either
compartment. T cells isolated from menstrual blood expressed increased levels of HLA-DR, aEb7 and CXCR4 and reduced
levels of CD62L relative to peripheral blood. Menstrual blood CD4+ T cells were enriched for cells expressing both CCR7 and
CD45RA, markers identifying naı ¨ve T cells and were functional as determined by antigen-specific intracellular cytokine
production assays. These data may open new avenues of investigation for cell mediated immune studies involving the
female reproductive tract without the need for biopsies.
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Introduction
The female reproductive tract is an integral part of the mucosal
immune system, and unlike other mucosal compartments, the
female reproductive tract is unique because it is required to
regulate immune responses that are necessary for protecting the
tissue from infectious pathogens while preserving the developing
fetus [1,2]. Thus, this compartment has several distinguishing
features that set it apart from other mucosal sites, and allow for
unique studies (reviewed in [3]).
Due to difficulties associated with obtaining cells from mucosal
tissues, most studies in humans on antigen-specific immune
responses at mucosal sites focus on the analysis of humoral
responses. However, the female reproductive tract has been shown
to possess the same type of cells present in the peripheral blood; in
fact lymphoid aggregates present in the cycling endometrium,
composed primarily of T cells, have been extensively described [4]
[5,6,7,8].
Studies in macaques have indicated the presence of antigen-
specific CD8+ T cells in the lower female genital tract [7].
Moreover, studies in humans employing T cells directly isolated
from various tissues, including the endometrium or obtained using
cytobrush-based sampling from the female reproductive tract have
also demonstrated that antigen-specific CD8+ cytotoxic T
lymphocyte (CTL) responses are present within this compartment
[9,10]. It has also been demonstrated that these responses are
under hormonal control such that CTL responses are lowest
during the secretory phase, when both estradiol and progesterone
concentrations are highest. Moreover, the highest CTL responses
were detected from samples obtained from postmenopausal
women where hormone levels are low [10].
The ability to induce antigen-specific T cell responses in the
reproductive tract allows for the study of cell-mediated immune
responses at mucosal sites in humans. It also provides the impetus
for the development of mucosal vaccines capable of protecting
against pathogens in these compartments. However, studies using
functional T lymphocytes, derived from mucosal tissue, to study
antigen-specific responses, T lymphocyte homing and develop-
ment are challenging due to the difficulty in obtaining genital
tissue from healthy women and isolating sufficient numbers of
cells.
The uterus is the main immunological organ in the human
female genital tract. It contributes most of the IgA for local
protection from pathogens [11] and a 90% decrease in the
immunoglobulin level from cervical mucus has been shown in
hysteterectomized women [12]. Based on this information we
sought to determine if the endometrium would also be a source of
T cells for the female genital tract that mediated many of the
cellular immune responses in this compartment. Menstrual blood,
which contains endometrial tissue, is likely to be enriched with
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characterized lymphocytes from menstrual blood in order to
determine whether this material would be an accurate represen-
tation of endometrium-derived T cells from which a plethora of
cellular mediated immunological assays could be performed.
Materials and Methods
Subjects
Menstruating healthy women (N=12) and 6 chronically HIV-
infected women (for the intracellular cytokine studies only), were
recruited from the University of Alabama at Birmingham (UAB) to
donate menstrual blood and peripheral blood. Menstrual cups
(Diva International, Inc, Kitchener, Ontario) were given to
volunteers prior to menstruation and instructions on how to use.
Contents of the Diva cup were decanted into 50 ml tubes
containing the following: fungizone (0.5 mg/ml), penicillin/strep-
tomycin (100 U/ml) and gentamicin (100 mg/ml) plus ACD
(5 mls/tube). Concentrations were determined assuming 25 ml
of menstrual blood/tube. Samples were kept at room temperature
and brought to the laboratory within 6 hours of collection. In
addition seven endometrial tissue samples, derived as anonymous
remnant surgical material, were obtained from otherwise healthy
women undergoing a hysterectomy. Written informed consent was
obtained from all women who participated in this study. The
Institutional Review Board of the University of Alabama at
Birmingham approved the study.
Isolation of menstrual blood cells
Menstrual blood was obtained from women on day 1 and/or 2
of the menstrual cycle. Menstrual Blood was diluted 1:2 in PBS,
without Ca
++/Mg
++. If the sample had excess mucus, we initially
tried to use collagenase and DTT to remove mucous, but addition
of these dramatically affected the expression of both CD62L
(lymph node homing receptor) and b7 (integrin) on the surface of
CD4+ and CD8+ T cells from menstrual and peripheral blood.
Following overnight incubation, some of the markers increased,
however, the level of expression was still different between the two
methods of isolation (data not shown). Therefore, in the studies
presented here menstrual blood cells were isolated without the use
of either collagenase or DTT. Instead, if sample had excess mucus,
it was diluted with PBS, and centrifuged at 400 x g for 10 mins.
Supernatant (SN) was pulled off as to not disturb cells and
volume replaced with fresh PBS before layering onto Histopaque
(Sigma-Aldrich, St. Louis, MO) and centrifuged at 800 x g for
25 min. RT. Interface containing buffy coat was removed, PBS
was added and spun down at 400 x g for 10 minutes twice. If cell
pellet contained RBC, it was spun down, supernatant discarded,
and pellet re-suspended. To the pellet, 5 mL cold ACK was added
for 5 min. Cell lysis was stopped by filling tube with PBS and
centrifuged at 400 x g for 10 min. Supernatant was discarded. If
pellet still appeared to have RBC, this procedure was repeated up
to two more times. Cell pellet was then resuspended in media. If
the sample contained too many particulates, the cell suspension
was passed through a 70 mM nylon cell strainer (BD Falcon,
Franklin Lakes, NJ) to remove residual tissue. PBMC were
obtained by standard Histopaque (Sigma-Aldrich, St. Louis, MO)
density centrifugation. Cells were counted and used for surface
staining and/or intracellular cytokine assays.
Isolation and purification of lymphocytes from
endometrial tissue
Lymphocytes were isolated from tissue segments by dissecting
and mincing tissue with surgical scissors to mechanically release
the intraepithelial cells and generate a cell suspension. This
suspension was passed through a 70 mM nylon cell strainer (BD
Falcon, Franklin Lakes, NJ) to remove residual tissue. The
remaining cell suspension was washed in RPMI containing 10%
AB serum by centrifugation (250 X g for 10 mins). Cells were
counted and used for surface marker staining.
Surface Marker Staining. Phenotypic characterization of
menstrual blood cells (MBC), endometrial tissue and PBMC
employed cell-surface markers CD3-Pacific Blue, CD8-PercpCy5.5
or PE, b7-PE, CD29-PE (b1), CD49d-APC (a4), CD62L-FITC,
CD103-FITC (aEb7), HLA-DR-FITC, CD45RO-PeCy7, CD45RA-
APC, CD27-PE, CD195-PeCy7 (CCR5), CD197-PECy7 (CCR7),
and CD184-APC (CXCR4) (Becton Dickinson, San Jose, CA, USA)
and CD4-Alexa750 (eBioscience, San Diego, CA) grouped into five
different stains containing 7 different flourochromes in order to
maximize information gathered while minimizing the total number of
cells needed. For a4b7 analysis, cells were first gated using a4a n d
either CD4 or CD8 after gating on CD3+CD4+ or CD3+CD8+ cells.
Then cells were selected from CD45R0+b7+gates. In addition, CD19-
PeCy7 (B-cells), CD14-PercpCy5.5 (monocytes) and CD56-APC/
CD16-PE (NK cells) stains were used to characterize cell composition
of the menstrual blood versus PBMC (Becton Dickinson, San Jose, CA,
USA). Stained cells were acquired using a BD LSRII flow cytometer
(Becton Dickinson [BD], San Jose, CA) and analyzed with FlowJo
Version 8.8.6 software (TreeStar, San Carlos, CA). We ran at least
100,000 gated lymphocytes for each stained specimen.
Antigens. CMV-pp65 peptide pool (69 18-mers, overlapping
by 10 spanning the entire amino acid sequence of the HCMV
pp65 protein, New England Peptide, Gardner, MA) (2 mg/ml) or
CMV-Lysate (Advance Biotechnologies, Columbia, MD) (2 mg/
ml) was used to stimulate T cells. PMA/Ionomycin (25 ng/ml and
500 ng/ml respectively) were used as a positive control.
Intracellular cytokine staining. Intracellular cytokine
staining was performed as previously described [13]. MBC and
PBMC were resuspended in RPMI containing 10% human AB
serum and co-stimulatory monoclonal antibodies (anti-CD28 and
anti-CD49d; each at 1 mg/ml) were added to each tube along with
50 U/ml of Benzonase (Novagen, Madison, WI). Cells were
pulsed with the appropriate antigen followed by the addition of
10 mg/ml Monensin (Golgistop, BD Biosciences, San Jose, CA)
and Brefeldin-A (Golgiplug, BD Biosciences, San Jose, CA). Cells
were then incubated at 37uC, 5% CO2 for 5 hours, and placed at
4uC ON. The following day cells were labeled with a fluorescent
LIVE/DEAD fixable Dead cell Stain (Molecular probes,
Invitrogen, CA). The surface phenotype of samples was
determined by staining with anti-CD3-Pacific Blue, anti-CD4-
PercpCy5.5, and anti-CD8-PE antibodies (BD Biosciences, San
Jose, CA, USA) for 20 min. at room temperature. Cells were
washed in PBS, followed by permeabilization with the Cytofix/
cytoperm reagent (BD, San Jose, CA) for 20 min. at room
temperature in the dark. Intracellular cytokine staining follows
using anti-TNF-a?Pecy7, and anti-IFN-cAlexa700 conjugated
antibodies (BD Biosciences, San Jose, CA, USA). At least
100,000 lymphocytes were acquired from each sample using a
BD LSR II flow cytometer (Becton Dickinson [BD], San Jose,
CA). Data were analyzed using FlowJo Version 8.5 software
(TreeStar, San Carlos, CA). Lymphocytes were analyzed based on
forward and side scatter profiles after the exclusion of dead cells.
Cytokines produced were measured off the CD3+CD4+ or
CD3+CD8+ gates relative to the media control values and these
gates were applied to all samples with different antigens from the
same individual.
Statistics. Statistical analyses were performed using the non-
parametric Wilcoxon Signed Rank test when linked samples (i.e.
T Lymphocytes from Menstrual Blood
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compared. When comparisons were made against samples
obtained from different individuals (i.e. PBMC or menstrual
blood and endometrium), Mann-Whitney U test was used.
Analyses were done with Graphpad Prism software 4.0 for Mac.
Differences were considered to be significant on the basis of 95%
confidence intervals (i.e. p,0.05).
Results
Menstrual blood cell composition
Cells obtained from menstrual and peripheral blood were
analyzed by staining for antigenic markers of T cells (CD3+CD4+
& CD3+CD8+), B cells (CD3-CD19+), NK cells (CD3-
CD56+CD16+ & CD3-CD56+CD16-) and monocytes (CD3-
CD14+), the predominant populations present in PBMC (Figure 1).
Significant differences between peripheral blood and menstrual
blood were seen for all the lymphocyte populations (total, B cells,
T cells and NK cells); however, no differences were noted for
monocytes (Figure 2A). The immunomodulatory subset of NK
cells (CD3-CD16-CD56+) present in menstrual blood, was
enriched when compared to peripheral blood (Figure 2C).
Conversely, the percentage of cytotoxic NK cells (CD3-
CD16+CD56+) was lower in cells obtained from menstrual blood.
Comparison of surface marker expression
To determine the source of lymphocytes present in menstrual
blood (i.e. mucosal or systemic), we compared the cell surface
markers expressed on cells obtained from menstrual and
peripheral blood and endometrial surgical samples. Sample flow
plots, gated on CD3+CD4+ and CD3+CD8+ T cells for analysis
of one homing and one retention receptor, respectively (CD62L
and aEb7) and an activation marker (HLA-DR), showed
differences among the samples (Figure 3). Specifically, the
percentages of CD4+ and CD8+ T cells isolated from MBC
expressing CD62L (lymph node homing receptor) were signifi-
cantly lower compared to PBMC but tended to be higher than
those isolated from the endometrium (Figure 3, 4A & D).
Conversely, the percentage of CD3+CD8+ T cells expressing the
mucosal retention receptor aEb7 (CD103) was higher on MBC
when compared to PBMC but lower compared to endometrium-
derived cells (Figure 3 and 4D). MBC CD4+ and CD8+ T cells
expressing a4b7 was more similar to the percentages observed in
PBMC than in endometrium (Figure 4A & D). Other differences
noted included an intermediate expression of HLA-DR in both
CD4+ and CD8+ T cells, when compared to PBMC and
endometrium, CD45R0 expression in menstrual blood cells that
mirrored PBMC and CD27 on MBC was more similar to
endometrium than PBMC (Figure 4B & E). Interestingly, CXCR4
was elevated on both CD4+ and CD8+ T cells from MBC
compared to both PBMC and endometrium (Figure 4C & F).
Lastly, no differences in the expression of the homing receptor
a4b1, often equated with homing to the genital mucosa, was seen
between menstrual blood and PBMC and due to limited sample,
a4b1 staining was not done for endometrial tissue samples by flow
cytometry (data not shown).
Memory marker expression among cellular subsets
Next, we stained for CD45RA and CCR7 markers, which have
been used to distinguish memory cell populations in the peripheral
blood [14]. CD4+ T cells from PBMC had a higher percentage of
CCR7+CD45RA- (central memory) cells relative to the MBC
(Figure 5A). In addition, menstrual blood CD4+ T cells had higher
percentage of CCR7+CD45RA+ (naı ¨ve) and CCR7-CD45RA+
(terminally differentiated) cells relative to PBMC (Figure 5B&D).
No differences were noted between cells from menstrual blood and
PBMC for the CD3+CD8+ T cells subsets.
The frequency of Ag-specific T cell responses
To address whether the T cells from the menstrual blood
compartment are able to respond to recall antigens, we performed
intracellular cytokine staining (ICCS) assays on PBMC from 7
Figure 1. Gating strategy for menstrual and peripheral blood
cells. A. PBMC and B. MBC. Initial gating is performed from the SSC-A
vs. FSC-A to determine the total lymphocyte gate (small gate) and the
larger gate is used to further gate for monocytes (CD14). From the
lymphocytes, live cells are gated, followed by gating B cells (CD19), T
cells (CD3), CD4+CD3+ and CD8+CD3+ cells. From the CD3- gate, NK
cell phenotypes are selected. CD16-CD56+(immunoregulatory cells) and
CD16+CD56+(Cytotoxic cells). Percentages of positive cells for a given
marker are indicated above/near gate.
doi:10.1371/journal.pone.0028894.g001
T Lymphocytes from Menstrual Blood
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peptides (stimulating both CD4 and CD8 T cells) or CMV lysate
(CD4 T cells only). Only a single healthy woman had detectable
CMV-specific CD4+ and CD8+ T cell responses obtained from
her menstrual blood; however these responses are reduced when
compared to PBMC (Figure 6A versus B). Because most of our
healthy volunteers did not have responses to CMV measured in
their PBMC, we chose to analyze MBC from women chronically
infected with HIV since their seroprevalance of CMV should be
increased (reviewed in [15]). Indeed, all 6 HIV seropositive women
studied had CMV T cell responses detected in their PBMC and
menstrual blood. When we compile the data from the one
uninfected woman with the data from the 6 HIV-seropositive
women, the reduction in CMV-specific T cells from the menstrual
blood becomes readily apparent (Figure 7). In fact, in every
situation, the frequency of CMV-specific T cells is lower or similar
in the menstrual vs. peripheral blood.
Discussion
We undertook these studies to determine whether menstrual
blood cells can be used to analyze T cells present in the
endometrium since it has been previously reported that T cells
are the predominant lymphocyte from the adaptive immune
system in endometrial tissue [4,5,6,8]. However, the proportion of
T cell subsets present in menstrual blood seem to mimic the
peripheral blood such that both have a higher percentage of CD4+
T cells than CD8+ T cells, unlike the endometrium and other
Figure 2. Cell composition of menstrual blood cells (MBCs). The percentage of various cell types present in menstrual blood versus PBMC
were resolved by staining with cell type-specific surface markers. A. The total lymphocytes, were determined by the percentage of cells within a
lymphocyte gate (small cells from FSC vs SSC plots) and monocytes (N=8), are CD14+ cell from a leuokocyte gate (all cells within the larger FSC vs
SSC plot), refer to Figure 1. B. Lymphocyte subsets present in menstrual versus peripheral blood. From the live cell gate, B cells were gated on CD19,
T cells were gated on CD3 and T cell subsets were further divided into CD4+CD3+ and CD8+CD3+ T cells. C. Natural killer cell subsets (N=8) gated
from CD3- cells. CD16+CD56+ (cytotoxic NK cells) and CD16-CD56+ (immunoregulatory NK cells). The median is shown for data from 12 healthy
women, except for monocytes and NK cells, where 8 samples were analyzed. Statistically significant differences (p,0.05) were obtained using
Wilcoxon Signed Rank test.
doi:10.1371/journal.pone.0028894.g002
Figure 3. A representative example of surface antigen expression. Cell surface expression of CD62L, HLA-DR and aEb7o nA. CD3+CD4+ and
B. CD3+CD8+ T cells from PBMC, MBC and endometrial tissue (ENDO) is shown. Percent of positive cells for a given marker are indicated above the
gate.
doi:10.1371/journal.pone.0028894.g003
T Lymphocytes from Menstrual Blood
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characterized the mononuclear cells present in menstrual blood
and showed that many of the T cells present in menstrual blood
share similar surface marker expression as those derived from the
endometrium. Although the percent monocytes is similar to
PBMC, menstrual blood has about 5 fold less total lymphocytes
(SSC vs. FCS gate) when compared to PBMC (Median 42% vs
9%, Figure 2A), similar to that reported for other tissue from the
female reproductive tract [5]. These differences remained similar
when subsets of samples were also analyzed using SSC versus
CD45 to gate mononuclear cells (data not shown).
NK cells, a major cell type of the innate immune response, are
also present in menstrual blood (Figure 1 and 2C). NK cells can be
divided into two main subtypes: cytolytic NK cells (CD16+
Figure 4. Surface marker expression on PBMC, MBC, and cells from endometrial tissue. Surface markers on CD3+CD4+ cells are shown for
panels A–C and on CD3+CD8+ on panels D–F. The median data from peripheral and menstrual blood is shown for 12 healthy women. Endometrial
tissue from 7 women was available for several analyses; however, for some samples, data from only four samples was obtained. Comparisons were
made using Wilcoxon Signed Rank test and Mann Whitney U test for paired and unpaired samples, respectively.
doi:10.1371/journal.pone.0028894.g004
T Lymphocytes from Menstrual Blood
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cytolytic regulatory NK cells (CD16-CD56+). In menstrual blood
the predominant subset express CD16-CD56+, the phenotype of
non-cytolytic regulatory NK cells, consistent with what has been
observed using uterine NK cells [19].
Menstrual blood T cells were also shown to be functional and
capable of responding to CMV, as measured by IFN-l secretion
using intracellular cytokine staining. Our data show that antigen-
specific responses are reduced in T cells obtained from menstrual
blood, unlike responses seen in other mucosal compartments such
as breast milk and cervical and vaginal tissue [20,21,22]. This
potential reduction in the number of antigen-specific cells in
menstrual blood maybe due to a reduction in the general
functional capacity of these cells as they respond to PMA/
Ionomycin, but their responsiveness is also reduced when
compared to PBMC (Figure 6). This lower level responsiveness
may be unique to this compartment, as other studies have also
demonstrated decreased function of antigen-specific T cells in cells
obtained from endometrial tissue when compared to the
peripheral blood [10,23].
To determine the origin of these cells, we measured the surface
expression of homing receptors such as CD62L and the retention
receptor aEb7 and found menstrual blood derived cells expressed
an intermediate level of these when compared to the endometrium
and PBMC. Endometrial T cells have been shown previously to
have an increase expression of HLA-DR relative to PBMC.
However, we found that although HLA-DR was elevated
compared to PBMC, it was not as elevated as endometrial tissue.
Based on this intermediate level of both homing receptors and
HLA-DR expression on menstrual blood derived T cells, it
appears that these lymphocytes may have originated from both the
endometrial and peripheral blood compartments, [16,24,25].
Previous data have demonstrated that T cells from tissue sections
of endometrium within lymphoid aggregates contained CD8+ T
cells where the vast majority (.90%) expressed CD45R0[18]. Our
results are inconsistent with these data since we only see this level
of CD45R0 expression from CD4+ T cells isolated from
endometrial tissue (Figure 4B), and the menstrual blood has
CD45R0+ levels analogous to PBMC (Figure 4B&E). However,
we cannot rule out the possibility that the cells derived from the
endometrium came from older women as compared to those
donating menstrual blood and as such these differences can be
ascribed to differences in age.
Epithelial cells and lymphocytes obtained from endometrial
samples were previously shown to express CCR5 (epithelial cells
and lymphocytes) and CXCR4 (epithelial cells only) [26,27].
These studies readily detected CCR5 on lymphocytes from the
ectocervix at all times points during the menstrual cycle. To our
knowledge there are no data on the expression of CXCR4 on T
cells from the endometrium or upper female genital tract. The
expression of CCR5 has been shown to be decreased during the
secretory phase of the menstrual cycle where progesterone and
estradiol are elevated, yet CXCR4 expression on epithelial cells
was not modulated by hormonal fluctuations due to the menstrual
cycle [25,26,27,28]. We demonstrated that both chemokine
receptors (CCR5 & CXCR4) are readily detected on CD4+ and
CD8+ T cells isolated from menstrual blood, however, CXCR4 is
significantly elevated when compared to both PBMC and
endometrial tissue.
The classification of memory cells and activation state of the
cells using CCR7 and CD45RA, respectively is useful when trying
to understand whether T cells are antigen experienced without the
use of antigen stimulation [14]. Prior data in breast milk
demonstrated that cells that have trafficked into the breast are
Figure 5. Memory marker expression. CCR7 and CD45RA surface staining was performed on both CD3+CD4+ and CD3+CD8+ T cells from PBMC
and MBC. A–D represent samples gated on different populations of cells CCR7 and CD45RA expression. The median and interquartile range data is
shown for 12 healthy women. Tcm=central memory, Tem=effector memory, and Temra=effector memory RA+. Comparisons were made using
Wilcoxon Signed Rank test.
doi:10.1371/journal.pone.0028894.g005
T Lymphocytes from Menstrual Blood
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phenotype exemplifies cells that are poised to eliminate pathogens
and should not require further differentiation. However, our
results (Figure 5) suggest that menstrual blood CD4+ T cells are
predominantly CCR7+CD45RA+ (naı ¨ve cells) consistent with cells
emerging from a lymphoid organ. The endometrium is not a
lymphoid organ and thus should not be capable of signaling T cells
to differentiate. As such, finding a predominance of CD4+ naı ¨ve T
cells in this compartment was unexpected. More recently, a
consensus was adopted whereby CD45RA, CCR7, CD27 and
CD28 markers should be used for the phenotyping of T cell
differentiation subsets [30]; however it was previously shown, that
CD45RA+CCR7+ cells uniformly co-express CD27 and
CD28[31]. We also confirmed in our dataset that naı ¨ve cells, as
phenotyped by CD45RA+ CCR7+ dual staining, also predomi-
nately express CD27 and CD28 (data not shown). The low
frequency of CMV-specific responses detected relative to PBMC
can also be explained by this predominance of naı ¨ve cells
(Figure 6A versus 6B and Figure 7).
Recently, hematopoetic stem cells (HCS) and lymphoid
progenitors in endometrium expressing CD45RA were described
[32]. In the stem cell literature CXCR4 is considered a homing
receptor [33,34] and recently multipotent stem cells have been
isolated from menstrual blood [35] and endometrium [36,37].
These published findings are consistent with the CXCR4 and
CD45RA+ data presented in this manuscript suggesting that both
Figure 6. CMV-specific T cells derived from the menstrual blood. A. PBMC B. MBC from the same healthy woman (#1). Cells were stimulated
with overlapping peptides from CMV pp65 and PMA/I as a positive control. Both IFN-c and TNF-a secretion are shown. Percent of cytokine positive
cells (IFN-c or TNF-a) are shown above the gate.
doi:10.1371/journal.pone.0028894.g006
T Lymphocytes from Menstrual Blood
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The monthly regenerative capacity of the endometrium, supports
the idea that a subset of menstrual blood CD4 T cells are
composed of multipotent cells and has important implications for
the establishment of local genital tract lymphocyte repertoires and
their regulation and function.
Although obtaining endometrial tissue without the use of a
biopsy is an attractive possibility, there are drawbacks for using
menstrual blood for the study of endometrial biology. First, the
hormonal changes due to the menstrual cycle cannot be followed
by using these cells i.e. only one window available to study with
these samples. In addition, using menstrual blood is not possible in
post-menopausal women or women taking hormonal contracep-
tives that prevent menstruation. However, although the lympho-
cytes present in menstrual blood are most likely of mixed origin:
blood and endometrium, these cells phenotypically are enriched
for cells derived from a mucosal compartment (decreased CD62L
and increased aEb7 expression). Clearly, for certain studies
menstrual blood won’t replace the use of endometrial biopsies
but may be used as a stepping-stone to determine if further studies
are warranted before the use of biopsies.
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